APO Research
Talk to an analyst

APO RESEARCH · REPORT

Paroxetine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Paroxetine Industry Growth and Trends Forecast to 2032

22 December 2025107 pages

Choose your research edition.

Industry ResearchParoxetine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Paroxetine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Paroxetine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Paroxetine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Paroxetine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Paroxetine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Paroxetine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Paroxetine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Paroxetine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Paroxetine include Teva, Sun Pharmaceutical, Mylan, Aurobindo, Sebela Pharmaceuticals, Neurocon Inc, Lupin, Lifegenix and Lannett Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Paroxetine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Paroxetine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Paroxetine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Paroxetine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Paroxetine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Paroxetine Market by Company

Teva

Sun Pharmaceutical

Mylan

Aurobindo

Sebela Pharmaceuticals

Neurocon Inc

Lupin

Lifegenix

Lannett Company

Jubilant Pharma

Apotex

Paroxetine Segment by Type

Paroxetine Hydrochloride Drug

Paroxetine Mesylate Drug

Paroxetine Segment by Application

Depression

Social anxiety disorder

Panic disorder

Others

Paroxetine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paroxetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Paroxetine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paroxetine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Paroxetine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Paroxetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Paroxetine Hydrochloride Drug Table 2. Major Company of Paroxetine Mesylate Drug Table 3. Global Paroxetine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Paroxetine Sales by Type (2021-2026) & (k units) Table 5. Global Paroxetine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Paroxetine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Paroxetine Sales Market Share in Value by Type (2021-2026) Table 8. Global Paroxetine Price by Type (2021-2026) & (US$/unit) Table 9. Global Paroxetine Sales by Type (2027-2032) & (k units) Table 10. Global Paroxetine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Paroxetine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Paroxetine Sales Market Share in Value by Type (2027-2032) Table 13. Global Paroxetine Price by Type (2027-2032) & (US$/unit) Table 14. North America Paroxetine Sales by Type (2021-2026) & (k units) Table 15. North America Paroxetine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Paroxetine Sales by Type (2021-2026) & (k units) Table 17. Europe Paroxetine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Paroxetine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Paroxetine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Paroxetine Sales by Type (2021-2026) & (k units) Table 21. Latin America Paroxetine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Paroxetine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Paroxetine Sales by Type (2021-2026) & (US$ Million) Table 24. Paroxetine Industry Trends Table 25. Paroxetine Industry Drivers Table 26. Paroxetine Industry Opportunities and Challenges Table 27. Paroxetine Industry Restraints Table 28. Global Paroxetine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Paroxetine Revenue Market Share by Company (2021-2026) Table 30. Global Paroxetine Sales by Company (2021-2026) & (k units) Table 31. Global Paroxetine Sales Share by Company (2021-2026) Table 32. Global Paroxetine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Paroxetine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Paroxetine Major Company Production Sites and Headquarters Table 35. Global Paroxetine Company, Product Type & Application Table 36. Global Paroxetine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Paroxetine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Paroxetine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Paroxetine Sales by Region (2021-2026) & (k units) Table 41. Global Paroxetine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Paroxetine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Paroxetine Sales Market Share in Value by Region (2021-2026) Table 44. Global Paroxetine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Paroxetine Sales by Region (2027-2032) & (k units) Table 46. Global Paroxetine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Paroxetine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Paroxetine Sales Market Share in Value by Region (2027-2032) Table 49. Global Paroxetine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Paroxetine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Paroxetine Sales by Application (2021-2026) & (k units) Table 52. Global Paroxetine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Paroxetine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Paroxetine Sales Market Share in Value by Application (2021-2026) Table 55. Global Paroxetine Price by Application (2021-2026) & (US$/unit) Table 56. Global Paroxetine Sales by Application (2027-2032) & (k units) Table 57. Global Paroxetine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Paroxetine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Paroxetine Sales Market Share in Value by Application (2027-2032) Table 60. Global Paroxetine Price by Application (2027-2032) & (US$/unit) Table 61. North America Paroxetine Sales by Application (2021-2026) & (k units) Table 62. North America Paroxetine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Paroxetine Sales by Application (2021-2026) & (k units) Table 64. Europe Paroxetine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Paroxetine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Paroxetine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Paroxetine Sales by Application (2021-2026) & (k units) Table 68. Latin America Paroxetine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Paroxetine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Paroxetine Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Teva Paroxetine Product Portfolio Table 75. Teva Recent Development Table 76. Sun Pharmaceutical Company Information Table 77. Sun Pharmaceutical Business Overview Table 78. Sun Pharmaceutical Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sun Pharmaceutical Paroxetine Product Portfolio Table 80. Sun Pharmaceutical Recent Development Table 81. Mylan Company Information Table 82. Mylan Business Overview Table 83. Mylan Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Mylan Paroxetine Product Portfolio Table 85. Mylan Recent Development Table 86. Aurobindo Company Information Table 87. Aurobindo Business Overview Table 88. Aurobindo Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Aurobindo Paroxetine Product Portfolio Table 90. Aurobindo Recent Development Table 91. Sebela Pharmaceuticals Company Information Table 92. Sebela Pharmaceuticals Business Overview Table 93. Sebela Pharmaceuticals Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Sebela Pharmaceuticals Paroxetine Product Portfolio Table 95. Sebela Pharmaceuticals Recent Development Table 96. Neurocon Inc Company Information Table 97. Neurocon Inc Business Overview Table 98. Neurocon Inc Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Neurocon Inc Paroxetine Product Portfolio Table 100. Neurocon Inc Recent Development Table 101. Lupin Company Information Table 102. Lupin Business Overview Table 103. Lupin Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Lupin Paroxetine Product Portfolio Table 105. Lupin Recent Development Table 106. Lifegenix Company Information Table 107. Lifegenix Business Overview Table 108. Lifegenix Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Lifegenix Paroxetine Product Portfolio Table 110. Lifegenix Recent Development Table 111. Lannett Company Company Information Table 112. Lannett Company Business Overview Table 113. Lannett Company Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Lannett Company Paroxetine Product Portfolio Table 115. Lannett Company Recent Development Table 116. Jubilant Pharma Company Information Table 117. Jubilant Pharma Business Overview Table 118. Jubilant Pharma Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Jubilant Pharma Paroxetine Product Portfolio Table 120. Jubilant Pharma Recent Development Table 121. Apotex Company Information Table 122. Apotex Business Overview Table 123. Apotex Paroxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Apotex Paroxetine Product Portfolio Table 125. Apotex Recent Development Table 126. North America Paroxetine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. North America Paroxetine Sales by Country (2021-2026) & (k units) Table 128. North America Paroxetine Sales Market Share by Country (2021-2026) Table 129. North America Paroxetine Sales Forecast by Country (2027-2032) & (k units) Table 130. North America Paroxetine Sales Market Share Forecast by Country (2027-2032) Table 131. North America Paroxetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Paroxetine Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Paroxetine Market Share by Country (2021-2026) Table 134. North America Paroxetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Paroxetine Market Share Forecast by Country (2027-2032) Table 136. Europe Paroxetine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Europe Paroxetine Sales by Country (2021-2026) & (k units) Table 138. Europe Paroxetine Sales Market Share by Country (2021-2026) Table 139. Europe Paroxetine Sales Forecast by Country (2027-2032) & (k units) Table 140. Europe Paroxetine Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Paroxetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Paroxetine Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Paroxetine Market Share by Country (2021-2026) Table 144. Europe Paroxetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Paroxetine Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Paroxetine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Paroxetine Sales by Country (2021-2026) & (k units) Table 148. Asia-Pacific Paroxetine Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Paroxetine Sales Forecast by Country (2027-2032) & (k units) Table 150. Asia-Pacific Paroxetine Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Paroxetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Paroxetine Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Paroxetine Market Share by Country (2021-2026) Table 154. Asia-Pacific Paroxetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Paroxetine Market Share Forecast by Country (2027-2032) Table 156. Latin America Paroxetine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Latin America Paroxetine Sales by Country (2021-2026) & (k units) Table 158. Latin America Paroxetine Sales Market Share by Country (2021-2026) Table 159. Latin America Paroxetine Sales Forecast by Country (2027-2032) & (k units) Table 160. Latin America Paroxetine Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Paroxetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Paroxetine Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Paroxetine Market Share by Country (2021-2026) Table 164. Latin America Paroxetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Paroxetine Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Paroxetine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Paroxetine Sales by Country (2021-2026) & (k units) Table 168. Middle East and Africa Paroxetine Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Paroxetine Sales Forecast by Country (2027-2032) & (k units) Table 170. Middle East and Africa Paroxetine Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Paroxetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Paroxetine Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Paroxetine Market Share by Country (2021-2026) Table 174. Middle East and Africa Paroxetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Paroxetine Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Paroxetine Distributors List Table 179. Paroxetine Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Paroxetine Image Figure 2. Global Paroxetine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Paroxetine Market Size (2021-2032) & (US$ Million) Figure 4. Global Paroxetine Sales (2021-2032) & (k units) Figure 5. Paroxetine Hydrochloride Drug Image Figure 6. Global Paroxetine Hydrochloride Drug Sales YoY Growth (2021-2032) & (k units) Figure 7. Paroxetine Mesylate Drug Image Figure 8. Global Paroxetine Mesylate Drug Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Paroxetine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Paroxetine Market Share by Type 2025 VS 2032 Figure 11. North America Paroxetine Sales Market Share in Volume by Type in 2025 Figure 12. North America Paroxetine Sales Market Share in Value by Type in 2025 Figure 13. Europe Paroxetine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Paroxetine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Paroxetine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Paroxetine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Paroxetine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Paroxetine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Paroxetine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Paroxetine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Paroxetine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Depression Image Figure 24. Global Depression Sales YoY Growth (2021-2032) & (k units) Figure 25. Social anxiety disorder Image Figure 26. Global Social anxiety disorder Sales YoY Growth (2021-2032) & (k units) Figure 27. Panic disorder Image Figure 28. Global Panic disorder Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Paroxetine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Paroxetine Market Share by Application 2025 VS 2032 Figure 33. North America Paroxetine Sales Market Share in Volume by Application in 2025 Figure 34. North America Paroxetine Sales Market Share in Value by Application in 2025 Figure 35. Europe Paroxetine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Paroxetine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Paroxetine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Paroxetine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Paroxetine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Paroxetine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Paroxetine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Paroxetine Sales Market Share in Value by Application in 2025 Figure 43. North America Paroxetine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Paroxetine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Paroxetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Paroxetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Paroxetine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Paroxetine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Paroxetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Paroxetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Paroxetine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Paroxetine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Paroxetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Paroxetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Paroxetine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Paroxetine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Paroxetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Paroxetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Paroxetine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Paroxetine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Paroxetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Paroxetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Paroxetine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Paroxetine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Paroxetine Hydrochloride Drug
  • Paroxetine Mesylate Drug
Applications
  • Depression
  • Social anxiety disorder
  • Panic disorder
  • Others
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Mylan
  • Aurobindo
  • Sebela Pharmaceuticals
  • Neurocon Inc
  • Lupin
  • Lifegenix
  • Lannett Company
  • Jubilant Pharma
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Paroxetine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Paroxetine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Paroxetine Market by Type
  6. 1.3.1 Paroxetine Hydrochloride Drug
  7. 1.3.2 Paroxetine Mesylate Drug
  8. 1.4 Global Paroxetine Market Size by Type
  9. 1.4.1 Global Paroxetine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Paroxetine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Paroxetine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Paroxetine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Paroxetine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Paroxetine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Paroxetine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Paroxetine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Paroxetine Industry Trends
  2. 2.2 Paroxetine Industry Drivers
  3. 2.3 Paroxetine Industry Opportunities and Challenges
  4. 2.4 Paroxetine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Paroxetine Revenue (2021-2026)
  2. 3.2 Global Top Players by Paroxetine Sales (2021-2026)
  3. 3.3 Global Top Players by Paroxetine Price (2021-2026)
  4. 3.4 Global Paroxetine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Paroxetine Major Company Production Sites & Headquarters
  6. 3.6 Global Paroxetine Company, Product Type & Application
  7. 3.7 Global Paroxetine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Paroxetine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Paroxetine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Paroxetine Tier 1, Tier 2, and Tier 3
4 Paroxetine Regional Status and Outlook
  1. 4.1 Global Paroxetine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Paroxetine Historic Market Size by Region
  3. 4.2.1 Global Paroxetine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Paroxetine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Paroxetine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Paroxetine Forecasted Market Size by Region
  7. 4.3.1 Global Paroxetine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Paroxetine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Paroxetine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Paroxetine by Application
  1. 5.1 Paroxetine Market by Application
  2. 5.1.1 Depression
  3. 5.1.2 Social anxiety disorder
  4. 5.1.3 Panic disorder
  5. 5.1.4 Others
  6. 5.2 Global Paroxetine Market Size by Application
  7. 5.2.1 Global Paroxetine Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Paroxetine Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Paroxetine Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Paroxetine Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Paroxetine Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Paroxetine Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Paroxetine Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Paroxetine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Paroxetine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Paroxetine Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sun Pharmaceutical
  8. 6.2.1 Sun Pharmaceutical Company Information
  9. 6.2.2 Sun Pharmaceutical Business Overview
  10. 6.2.3 Sun Pharmaceutical Paroxetine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical Paroxetine Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Paroxetine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Paroxetine Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Aurobindo
  20. 6.4.1 Aurobindo Company Information
  21. 6.4.2 Aurobindo Business Overview
  22. 6.4.3 Aurobindo Paroxetine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Aurobindo Paroxetine Product Portfolio
  24. 6.4.5 Aurobindo Recent Developments
  25. 6.5 Sebela Pharmaceuticals
  26. 6.5.1 Sebela Pharmaceuticals Company Information
  27. 6.5.2 Sebela Pharmaceuticals Business Overview
  28. 6.5.3 Sebela Pharmaceuticals Paroxetine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sebela Pharmaceuticals Paroxetine Product Portfolio
  30. 6.5.5 Sebela Pharmaceuticals Recent Developments
  31. 6.6 Neurocon Inc
  32. 6.6.1 Neurocon Inc Company Information
  33. 6.6.2 Neurocon Inc Business Overview
  34. 6.6.3 Neurocon Inc Paroxetine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Neurocon Inc Paroxetine Product Portfolio
  36. 6.6.5 Neurocon Inc Recent Developments
  37. 6.7 Lupin
  38. 6.7.1 Lupin Company Information
  39. 6.7.2 Lupin Business Overview
  40. 6.7.3 Lupin Paroxetine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lupin Paroxetine Product Portfolio
  42. 6.7.5 Lupin Recent Developments
  43. 6.8 Lifegenix
  44. 6.8.1 Lifegenix Company Information
  45. 6.8.2 Lifegenix Business Overview
  46. 6.8.3 Lifegenix Paroxetine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lifegenix Paroxetine Product Portfolio
  48. 6.8.5 Lifegenix Recent Developments
  49. 6.9 Lannett Company
  50. 6.9.1 Lannett Company Company Information
  51. 6.9.2 Lannett Company Business Overview
  52. 6.9.3 Lannett Company Paroxetine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Lannett Company Paroxetine Product Portfolio
  54. 6.9.5 Lannett Company Recent Developments
  55. 6.10 Jubilant Pharma
  56. 6.10.1 Jubilant Pharma Company Information
  57. 6.10.2 Jubilant Pharma Business Overview
  58. 6.10.3 Jubilant Pharma Paroxetine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jubilant Pharma Paroxetine Product Portfolio
  60. 6.10.5 Jubilant Pharma Recent Developments
  61. 6.11 Apotex
  62. 6.11.1 Apotex Company Information
  63. 6.11.2 Apotex Business Overview
  64. 6.11.3 Apotex Paroxetine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Apotex Paroxetine Product Portfolio
  66. 6.11.5 Apotex Recent Developments
7 North America by Country
  1. 7.1 North America Paroxetine Sales by Country
  2. 7.1.1 North America Paroxetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Paroxetine Sales by Country (2021-2026)
  4. 7.1.3 North America Paroxetine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Paroxetine Market Size by Country
  6. 7.2.1 North America Paroxetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Paroxetine Market Size by Country (2021-2026)
  8. 7.2.3 North America Paroxetine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Paroxetine Sales by Country
  2. 8.1.1 Europe Paroxetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Paroxetine Sales by Country (2021-2026)
  4. 8.1.3 Europe Paroxetine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Paroxetine Market Size by Country
  6. 8.2.1 Europe Paroxetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Paroxetine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Paroxetine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Paroxetine Sales by Country
  2. 9.1.1 Asia-Pacific Paroxetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Paroxetine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Paroxetine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Paroxetine Market Size by Country
  6. 9.2.1 Asia-Pacific Paroxetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Paroxetine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Paroxetine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Paroxetine Sales by Country
  2. 10.1.1 South America Paroxetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Paroxetine Sales by Country (2021-2026)
  4. 10.1.3 South America Paroxetine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Paroxetine Market Size by Country
  6. 10.2.1 South America Paroxetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Paroxetine Market Size by Country (2021-2026)
  8. 10.2.3 South America Paroxetine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Paroxetine Sales by Country
  2. 11.1.1 Middle East and Africa Paroxetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Paroxetine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Paroxetine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Paroxetine Market Size by Country
  6. 11.2.1 Middle East and Africa Paroxetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Paroxetine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Paroxetine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Paroxetine Value Chain Analysis
  2. 12.1.1 Paroxetine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Paroxetine Production Mode & Process
  7. 12.2 Paroxetine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Paroxetine Distributors
  10. 12.2.3 Paroxetine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst